German Cardiac Arrest Registry: rationale and design of G-CAR.
Janine Pöss, Christoph Sinning, Isabelle Schreiner...
https://pubmed.ncbi.nlm.nih.gov/35729429/Actively Recruiting
Led by Leipzig Heart Science gGmbH · Updated on 2026-02-12
400
Participants Needed
25
Research Sites
25 weeks
Total Duration
Researchers are studying patients who have experienced out-of-hospital cardiac arrest OHCA caused by heart-related issues. The goal is to better understand this condition by systematically collecting detailed information about patients medical background, treatment, and outcomes. This observational registry aims to improve care by analyzing data from a large number of patients in Germany, where many suffer from OHCA each year but survival with good brain function remains low. The study involves recording comprehensive data on each patient, including demographic details, psychosocial factors, disease progression, clinical and laboratory tests, and treatments received before, during, and after hospital care. There are no specific treatments assigned since this is an observational study focused on tracking and analyzing patient experiences and medical results. Participants will be followed throughout their hospital stay, which averages about two weeks, with researchers monitoring outcomes such as survival rates, length of intensive care and hospital stays, and health status at 6 and 12 months. This includes assessments of quality of life, mental health, cognitive function, and ability to reintegrate socially. The study aims to gather valuable information to guide future improvements in OHCA patient care.
CONDITIONS
German Cardiac Arrest Registry
J
Janine Pöss, Dr.
H
Holger Thiele, Prof.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Leipzig Heart Science gGmbH
Lead Sponsor
Helios Health Institute GmbH
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Until discharge, an average of 2 weeks
Participants are observed during their hospital stay to collect data on mortality and length of stay.
Continuous monitoring during hospital stay
Duration - Up to 12 months
Participants are followed up to assess mortality, quality of life, psychological status, and cognitive function.
Follow-up assessments at 1 month, 6 months, and 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Janine Pöss, Christoph Sinning, Isabelle Schreiner...
https://pubmed.ncbi.nlm.nih.gov/35729429/Janine Pöss, Christoph Sinning, Michelle Roßberg...
https://pubmed.ncbi.nlm.nih.gov/38869632/Leipzig Heart Science gGmbH
Lead Sponsor
Helios Health Institute GmbH
Collaborating Sponsor